Abstract
Intratympanic injection of gentamicin is increasingly used in the treatment of unilateral disabling Menière’s disease (MD). Several objective functional and subjective tests have been developed to assess the control of vertigo after gentamicin treatment. The aim of this study was to show that subjective results require a vestibular deafferentation as profound as possible, evidenced with multifrequency vestibular assessment. Sixty four patients with intractable MD in situation of medical treatment failure longer than 6 months were included between 1998 and 2013 in this case control study. A 2-year follow-up was performed after the last intratympanic gentamicin performed with the titration technique. A vestibular assessment was applied before and after 2 years of treatment with a functional level score using the AAOHNS vertigo scale and multifrequency vestibular assessment: skull vibration-induced nystagmus test (SVINT), head-shaking test (HST) and caloric test (CaTe). The correlation between the results of the questionnaire and the level of the deafferentation as evaluated by the tests was analyzed with the Spearman test. Among the 64 included patients, 56 (87.5 %) described vertigo control. There was a correlation (=−0.33 [−0.53; −0.09], p = 0.008) between subjective improvement (AAO -HNS 1 or 2) and the degree of vestibular deafferentation as evidenced by a destructive nystagmus (beating toward the safe side) with the HST and the SVINT, as well as a caloric hypofunction >90 % with the CaTe. The present study demonstrates that a profound vestibular deafferentation confirmed with multifrequency test evaluation is needed to have a subjective improvement in the treatment of unilateral disabling MD with intratympanic gentamicin.
Similar content being viewed by others
References
Silverstein H, Smouha E, Jones R (1989) Natural history vs. surgery for Menière’s disease. Otolaryngol Head Neck Surg 100:6–16
(1995) Committee on hearing and equilibrium guidelines for the diagnosis and evaluation of therapy in Menière’s disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg 113:181–185
Reid CB, Eisenberg R, Halmagyi GM, Fagan PA (1996) The outcome of vestibular nerve section for intractable vertigo: the patient’s point of view. Laryngoscope 106:1553–1556
Magnan J, Bremond G, Chays A et al (1991) Vestibular neurotomy by retrosigmoid approach: technique, indications, and results. Am J Otol 12:101–104
Hillman TA, Chen DA, Arriaga MA (2004) Vestibular nerve section versus intratympanic gentamicin for Meniere’s disease. Laryngoscope 114:216–222
Yazdi AK, Rutka J (1996) Results of labyrinthectomy in the treatment of Menière’s disease and delayed endolymphatic hydrops. J Otolaryngol 25:26–31
Gacek RR, Gacek MR (1996) Comparison of labyrinthectomy and vestibular neurectomy in the control of vertigo. Laryngoscope 106:225–230
Atlas JT, Parnes LS (1999) Intratympanic gentamicin titration therapy for intractable Meniere’s disease. Am J Otol 20:357–363
Chia SH, Gamst AC, Anderson JP, Harris JP (2004) Intratympanic gentamicin therapy for Ménière’s disease: a meta-analysis. Otol Neurotol 25:544–552
Zhai F, Liu J-P, Dai C-F et al (2010) Evidence-based modification of intratympanic gentamicin injections in patients with intractable vertigo. Otol Neurotol 31:642–648
Silverstein H, Wazen J, Van Ess MJ et al (2010) Intratympanic gentamicin treatment of patients with Ménière’s disease with normal hearing. Otolaryngol Head Neck Surg 142:570–575
Morel N, Dumas G, Righini C et al (2008) Multifrequency vestibular study after vestibular neurotomy and chemical labyrinthectomy. Ann Otolaryngol Chir Cervicofac 125:139–145
Gode S, Celebisoy N, Akyuz A et al (2011) Single-shot, low-dose intratympanic gentamicin in Ménière disease: role of vestibular-evoked myogenic potentials and caloric test in the prediction of outcome. Am J Otolaryngol 32:412–416
Rohrmeier C, Richter O, Schneider M et al (2013) Triple test as predictive screen for unilateral weakness on caloric testing in routine practice. Otol Neurotol 34:297–303
Hain TC, Fetter M, Zee DS (1987) Head-shaking nystagmus in patients with unilateral peripheral vestibular lesions. Am J Otolaryngol 8:36–47
Curthoys IS, Burgess AM, MacDougall HG et al (2009) Testing human otolith function using bone-conducted vibration. Ann N Y Acad Sci 1164:344–346
Dumas G, Karkas A, Perrin P et al (2011) High-frequency skull vibration-induced nystagmus test in partial vestibular lesions. Otol Neurotol 32:1291–1301
MacDougall HG, Weber KP, McGarvie LA et al (2009) The video head impulse test: diagnostic accuracy in peripheral vestibulopathy. Neurology 73:1134–1141
Weber KP, MacDougall HG, Halmagyi GM, Curthoys IS (2009) Impulsive testing of semicircular-canal function using video-oculography. Ann N Y Acad Sci 1164:486–491
Bartl K, Lehnen N, Kohlbecher S, Schneider E (2009) Head impulse testing using video-oculography. Ann N Y Acad Sci 1164:331–333
De Waele C, Meguenni R, Freyss G et al (2002) Intratympanic gentamicin injections for Meniere disease: vestibular hair cell impairment and regeneration. Neurology 59:1442–1444
Picciotti PM, Fiorita A, Di Nardo W et al (2005) VEMPs and dynamic posturography after intratympanic gentamycin in Menière’s disease. J Vestib Res 15:161–168
Young Y-H (2006) Vestibular evoked myogenic potentials: optimal stimulation and clinical application. J Biomed Sci 13:745–751
Halmagyi GM (2005) Diagnosis and management of vertigo. Clin Med 5:159–165
Seemungal BM, Bronstein AM (2008) A practical approach to acute vertigo. Pract Neurol 8:211–221
Perez N, Rama-Lopez J (2005) Vestibular function at the end of intratympanic gentamicin treatment of patients with Ménière’s disease. J Vestib Res 15:49–58
Todd NPM, Rosengren SM, Colebatch JG (2009) A utricular origin of frequency tuning to low-frequency vibration in the human vestibular system? Neurosci Lett 451:175–180
Dumas G, Perrin P, Schmerber S (2008) Nystagmus induced by high frequency vibrations of the skull in total unilateral peripheral vestibular lesions. Acta Otolaryngol 128:255–262
Dimitri PS, Wall C, Rauch SD (2001) Multivariate vestibular testing: laterality of unilateral Ménière’s disease. J Vestib Res 11:405–412
Black FO, Kitch R (1980) A review of vestibular test results in Meniere’s disease. Otolaryngol Clin North Am 13:631–642
Ulmer E, Magnan J, Chays A (2002) Bilateral vestibular areflexia: quantification is required. Ann Otolaryngol Chir Cervicofac 119:216–226
Bodmer D, Morong S, Stewart C et al (2007) Long-term vertigo control in patients after intratympanic gentamicin instillation for Ménière’s disease. Otol Neurotol 28:1140–1144
Manzari L, Tedesco A-R, Burgess AM, Curthoys IS (2010) Ocular and cervical vestibular-evoked myogenic potentials to bone conducted vibration in Ménière’s disease during quiescence vs during acute attacks. Clin Neurophysiol 121:1092–1101
Proctor LR (2000) Results of serial vestibular testing in unilateral Ménière’s disease. Am J Otol 21:552–558
Diamond C, O’Connell DA, Hornig JD, Liu R (2003) Systematic review of intratympanic gentamicin in Meniere’s disease. J Otolaryngol 32:351–361
Huon L-K, Fang T-Y, Wang P-C (2012) Outcomes of intratympanic gentamicin injection to treat Ménière’s disease. Otol Neurotol 33:706–714
Pullens B, van Benthem PP (2011) Intratympanic gentamicin for Ménière’s disease or syndrome. Cochrane Database Syst Rev 16:CD008234
Cohen-Kerem R, Kisilevsky V, Einarson TR et al (2004) Intratympanic gentamicin for Menière’s disease: a meta-analysis. Laryngoscope 114:2085–2091
Okuda T, Sugahara K, Shimogori H, Yamashita H (2004) Inner ear changes with intracochlear gentamicin administration in Guinea pigs. Laryngoscope 114:694–697
Harner SG, Driscoll CL, Facer GW et al (2001) Long-term follow-up of transtympanic gentamicin for Ménière’s syndrome. Otol Neurotol 22:210–214
Kimura RS, Lee KS, Nye CL, Trehey JA (1991) Effects of systemic and lateral semicircular canal administration of aminoglycosides on normal and hydropic inner ears. Acta Otolaryngol 111:1021–1030
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interests
The authors declare that they have no conflict of interests.
Rights and permissions
About this article
Cite this article
Junet, P., Karkas, A., Dumas, G. et al. Vestibular results after intratympanic gentamicin therapy in disabling Menière’s disease. Eur Arch Otorhinolaryngol 273, 3011–3018 (2016). https://doi.org/10.1007/s00405-015-3889-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-015-3889-x